AcouSort AB (publ) (STO:ACOU)

Sweden · Delayed Price · Currency is SEK

2.220

-0.050 (-2.20%)

At close: Mar 6, 2026

-68.19% (1Y)

Market Cap	46.98M
Revenue (ttm)	10.43M
Net Income (ttm)	-12.15M
Shares Out	21.16M
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,944
Average Volume	31,506
Open	2.170
Previous Close	2.270
Day's Range	2.140 - 2.270
52-Week Range	2.030 - 4.680
Beta	0.07
RSI	37.37
Earnings Date	Feb 25, 2026

About AcouSort AB

AcouSort AB (publ), a technology company, develops components and instruments used in the diagnostics, analytics, and cell therapy processing markets. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an module that enables in-line analysis of blood plasma from whole blood samples; AQC Module, an in-line optical analysis of particle suspensions for quality control or monitoring applications; and AcouWash, a benchtop research instrumen... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2010

Employees 16

Stock Exchange Nasdaq Stockholm

Ticker Symbol ACOU

Full Company Profile

Financial Performance

In 2025, AcouSort AB's revenue was 10.43 million, an increase of 4.01% compared to the previous year's 10.03 million. Losses were -12.15 million, -19.40% less than in 2024.

Financial Statements

News

There is no news available yet.